FDA re­jects Van­da’s treat­ment for di­ges­tion con­di­tion, com­pa­ny re­bukes agen­cy's ac­tions

The FDA flashed a red light on Van­da Phar­ma­ceu­ti­cals’ ex­per­i­men­tal treat­ment for a gas­troin­testi­nal con­di­tion that dis­rupts the di­ges­tion process.

The agency re­ject­ed tradip­i­tant in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER